1. Xu, Nan, Ren, Yunpeng, Bao, Yufang, Xie, Gangcai, Wang, Yongbo. 2023. PUF60 promotes cell cycle and lung cancer progression by regulating alternative splicing of CDC25C. In Cell reports, 42, 113041. doi:10.1016/j.celrep.2023.113041. https://pubmed.ncbi.nlm.nih.gov/37682709/
2. Zhou, Xiaokun, Lu, Danping, Yi, Wenxiang, Xu, Dan. 2023. Downregulation of CDC25C in NPCs Disturbed Cortical Neurogenesis. In International journal of molecular sciences, 24, . doi:10.3390/ijms24021505. https://pubmed.ncbi.nlm.nih.gov/36675024/
3. Guo, Xingya, Li, Kai, Jiang, Weiliang, Pan, Qin, Wan, Rong. 2020. RNA demethylase ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of PER1 in an m6A-YTHDF2-dependent manner. In Molecular cancer, 19, 91. doi:10.1186/s12943-020-01158-w. https://pubmed.ncbi.nlm.nih.gov/32429928/
4. Hu, Gunchu, Li, Jian, Zeng, Yi, Liu, Kuijie, Yao, Hongliang. 2023. The anoikis-related gene signature predicts survival accurately in colon adenocarcinoma. In Scientific reports, 13, 13919. doi:10.1038/s41598-023-40907-x. https://pubmed.ncbi.nlm.nih.gov/37626132/
5. St Clair, Selvon, Manfredi, James J. 2006. The dual specificity phosphatase Cdc25C is a direct target for transcriptional repression by the tumor suppressor p53. In Cell cycle (Georgetown, Tex.), 5, 709-13. doi:. https://pubmed.ncbi.nlm.nih.gov/16582636/
6. Zhai, Meng, Miao, Jiyu, Zhang, Ru, He, Aili, Bai, Ju. 2024. KIF22 promotes multiple myeloma progression by regulating the CDC25C/CDK1/cyclinB1 pathway. In Journal of cancer research and clinical oncology, 150, 239. doi:10.1007/s00432-024-05747-w. https://pubmed.ncbi.nlm.nih.gov/38713252/
7. Yoshimi, Akihide, Toya, Takashi, Kawazu, Masahito, Mano, Hiroyuki, Kurokawa, Mineo. 2014. Recurrent CDC25C mutations drive malignant transformation in FPD/AML. In Nature communications, 5, 4770. doi:10.1038/ncomms5770. https://pubmed.ncbi.nlm.nih.gov/25159113/
智鼠故事 
